Medeon Biodesign, Inc. (TPEX:6499)
104.50
-1.50 (-1.42%)
Oct 31, 2025, 2:31 PM CST
Medeon Biodesign Revenue
Medeon Biodesign had revenue of 110.38M TWD in the quarter ending June 30, 2025, with 73.76% growth. This brings the company's revenue in the last twelve months to 394.40M, up 86.16% year-over-year. In the year 2024, Medeon Biodesign had annual revenue of 292.81M with 49.19% growth.
Revenue (ttm)
394.40M
Revenue Growth
+86.16%
P/S Ratio
24.41
Revenue / Employee
10.11M
Employees
39
Market Cap
9.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 292.81M | 96.55M | 49.19% |
| Dec 31, 2023 | 196.26M | -102.05M | -34.21% |
| Dec 31, 2022 | 298.32M | 229.36M | 332.61% |
| Dec 31, 2021 | 68.96M | -54.10M | -43.96% |
| Dec 31, 2020 | 123.06M | -330.71M | -72.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |